Effect of Anamorelin on Cachexia in Advanced NSCLC

Multimodal management of patients with advanced cancer and cachexiaПодробнее

Dr. Temel on Anorexia and Cachexia in NSCLCПодробнее

Anamorelin improves appetite and body mass in lung cancer with cancer anorexia-cachexiaПодробнее

Anamorelin for cachexia for patients with NSCLCПодробнее

Dr. Abernethy Discusses Anamorelin as a Treatment Option for Patients with Cancer Anorexia-CachexiaПодробнее

Phase III trials of anamorelin in patients with advanced NSCLC and cachexia (ROMANA 1 and 2)Подробнее

Phase III trials of anamorelin in patients with advanced NSCLC and cachexia (ROMANA 1 and 2)Подробнее

ROMANA 3 - A safety extension study of anamorelin in advanced NSCLC patients with cachexiaПодробнее

Dr. Temel Discusses Her Work on Anamorelin for Treating NSCLC Patients with Anorexia and CachexiaПодробнее

The Challenge of Cancer Cachexia - Jeffrey CrawfordПодробнее

Improving outcomes for patients with metastatic NSCLC with immunotherapyПодробнее

Combating cachexia: New approachesПодробнее

Treating cachecia with anamorelin: 24-week follow-up data from ROMANA studiesПодробнее

Prof. Currow Presents Results of a Phase III Trial on the Effects of AnamorelinПодробнее

Development of effective multi-dimensional interventions for patients with cancer cachexiaПодробнее

Applying what we’ve learned from clinical trials about cachexia to cancer survivorsПодробнее

NSCLC Workflows: Tumor EnrichmentПодробнее

Side Effect Management in Advanced Lung CancerПодробнее

ROMANA 3 - A safety extension study of anamorelin in advanced NSCLC patients with cachexiaПодробнее